- Report
- February 2023
- 287 Pages
Global
From €5309EUR$5,500USD£4,554GBP
- Drug Pipelines
- February 2020
- 81 Pages
Global
From €3378EUR$3,500USD£2,898GBP
- Report
- July 2023
- 81 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- November 2021
- 1032 Pages
Global
From €4826EUR$5,000USD£4,140GBP
Galectin 3 is a biomarker that is used to diagnose and monitor a variety of diseases, including cancer, cardiovascular disease, and inflammatory diseases. It is a member of the galectin family of proteins, which are involved in cell-cell and cell-matrix interactions. Galectin 3 has been studied extensively in the context of cancer, where it has been found to be associated with tumor progression and metastasis. It has also been linked to the development of cardiovascular disease, and has been used to monitor the progression of inflammatory diseases such as rheumatoid arthritis.
The Galectin 3 market is a rapidly growing field, with a number of companies offering products and services related to the biomarker. These include Abcam, Bio-Techne, Cell Signaling Technology, Creative Diagnostics, and RayBiotech. Show Less Read more